Kovai Medical Center & Hospital Ltd
Kovai Medical Center & Hospital Ltd is a Coimbatore-based company which is in the business of advanced healthcare services. It also forayed into education services in 2019 with the commencement of its new Medical College in Coimbatore.[1]
- Market Cap ₹ 6,180 Cr.
- Current Price ₹ 5,658
- High / Low ₹ 6,725 / 5,010
- Stock P/E 107
- Book Value ₹ 264
- Dividend Yield 0.18 %
- ROCE 24.1 %
- ROE 22.2 %
- Face Value ₹ 10.0
Pros
- Company has a good return on equity (ROE) track record: 3 Years ROE 25.5%
- Company's median sales growth is 19.0% of last 10 years
Cons
- Stock is trading at 21.4 times its book value
- Company might be capitalizing the interest cost
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Healthcare Services Hospital
Part of BSE Healthcare BSE 1000 BSE Hospitals
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 88 | 110 | 130 | 175 | 222 | 297 | 334 | 402 | 465 | 531 | 592 | |
| 73 | 91 | 104 | 138 | 178 | 226 | 261 | 307 | 373 | 406 | 463 | |
| Operating Profit | 15 | 19 | 26 | 37 | 44 | 71 | 73 | 95 | 92 | 125 | 129 |
| OPM % | 17% | 17% | 20% | 21% | 20% | 24% | 22% | 24% | 20% | 24% | 22% |
| 1 | 1 | 2 | 1 | 1 | 3 | 5 | 7 | 8 | 6 | 8 | |
| Interest | 3 | 4 | 5 | 11 | 17 | 27 | 24 | 20 | 17 | 15 | 13 |
| Depreciation | 5 | 4 | 5 | 7 | 13 | 16 | 16 | 22 | 21 | 24 | 34 |
| Profit before tax | 7 | 11 | 17 | 20 | 16 | 31 | 37 | 59 | 62 | 92 | 89 |
| Tax % | 41% | 35% | 33% | 38% | 26% | 33% | 36% | 35% | 35% | 35% | 35% |
| 4 | 7 | 12 | 12 | 12 | 20 | 24 | 39 | 41 | 60 | 58 | |
| EPS in Rs | 3.85 | 6.53 | 10.60 | 11.06 | 10.91 | 18.67 | 21.72 | 35.21 | 37.12 | 54.89 | 52.99 |
| Dividend Payout % | 32% | 19% | 12% | 11% | 11% | 8% | 7% | 4% | 7% | 5% | 6% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 15% |
| 3 Years: | 14% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 23% |
| 3 Years: | 15% |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 23% |
| 5 Years: | 35% |
| 3 Years: | 42% |
| 1 Year: | 2% |
| Return on Equity | |
|---|---|
| 10 Years: | 27% |
| 5 Years: | 27% |
| 3 Years: | 26% |
| Last Year: | 22% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 | 11 |
| Reserves | 13 | 19 | 29 | 40 | 50 | 68 | 90 | 126 | 163 | 223 | 278 |
| 38 | 70 | 108 | 192 | 228 | 209 | 184 | 163 | 158 | 125 | 202 | |
| 31 | 25 | 25 | 41 | 50 | 55 | 65 | 85 | 96 | 103 | 116 | |
| Total Liabilities | 93 | 126 | 173 | 283 | 338 | 344 | 350 | 384 | 428 | 462 | 606 |
| 62 | 69 | 106 | 193 | 295 | 285 | 282 | 285 | 342 | 358 | 444 | |
| CWIP | 6 | 20 | 42 | 38 | 0 | 5 | 5 | 17 | 10 | 6 | 13 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 25 | 36 | 25 | 53 | 43 | 54 | 62 | 83 | 76 | 99 | 149 | |
| Total Assets | 93 | 126 | 173 | 283 | 338 | 344 | 350 | 384 | 428 | 462 | 606 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 15 | 24 | 42 | 56 | 61 | 68 | 97 | 86 | 99 | 87 | ||
| -23 | -64 | -97 | -77 | -9 | -12 | -80 | -115 | -83 | -191 | ||
| 27 | 31 | 71 | 17 | -48 | -52 | -43 | -24 | -50 | 60 | ||
| Net Cash Flow | 18 | -9 | 16 | -3 | 5 | 4 | -26 | -53 | -34 | -45 | |
| Free Cash Flow | -8 | -41 | -56 | -21 | 51 | 53 | 60 | 15 | 63 | -41 | |
| CFO/OP | 97% | 113% | 123% | 136% | 96% | 103% | 119% | 110% | 100% | 92% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 14 | 11 | 12 | 14 | 5 | 5 | 8 | 9 | 7 | 8 | 9 |
| Inventory Days | 50 | 39 | 43 | 37 | 36 | 35 | 33 | 25 | 22 | 20 | 23 |
| Days Payable | 72 | 31 | 24 | 25 | 32 | 29 | 35 | 53 | 47 | 37 | 43 |
| Cash Conversion Cycle | -8 | 19 | 32 | 25 | 9 | 11 | 6 | -19 | -19 | -9 | -11 |
| Working Capital Days | -12 | -11 | -15 | -62 | -68 | -55 | -48 | -60 | -56 | -50 | -47 |
| ROCE % | 19% | 18% | 16% | 12% | 20% | 21% | 27% | 25% | 31% | 24% |
Insights
In beta| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Bed Capacity Beds ・Standalone data |
|
||||||||||
| Operating Beds Beds ・Standalone data |
|||||||||||
| Average Length of Stay (ALOS) Days ・Standalone data |
|||||||||||
| Average Revenue Per Occupied Bed (ARPOB) INR ・Standalone data |
|||||||||||
| Bed Occupancy Rate % ・Standalone data |
|||||||||||
| Number of Inpatients Nos ・Standalone data |
|||||||||||
| Number of Outpatients Nos ・Standalone data |
|||||||||||
Extracted by Screener AI
Documents
Announcements
-
Board Meeting Intimation for Considering The Audited Financials Results Of The Company For The Quarter / Year Ended 31St March, 2026.
25 Apr - Board meeting on 22 May 2026 to consider audited Q4/FY26 financial results; trading window remains closed.
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
13 Apr - Copies of Newspaper Advertisement published in English and Tamil in the Trinity Mirror and Makkal kural respectively, with regard to the Special window for Re-Lodgement …
- Shareholder Meeting / Postal Ballot-Scrutinizer"s Report 13 Apr
-
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
6 Apr - KMCH confirms it is not a Large Corporate under SEBI debt fundraising framework.
-
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
6 Apr - Certificate received from our RTA in compliance under regulation 74(5) of SEBI(DP) Regulations,2018 for the quarter ended 31.03.2026.
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Segments